BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 24706988)

  • 1. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients.
    McCarthy EM; Smith S; Lee RZ; Cunnane G; Doran MF; Donnelly S; Howard D; O'Connell P; Kearns G; Ní Gabhann J; Jefferies CA
    Rheumatology (Oxford); 2014 Sep; 53(9):1586-94. PubMed ID: 24706988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine imbalance in systemic lupus erythematosus: a study on northern Indian subjects.
    Arora V; Verma J; Marwah V; Kumar A; Anand D; Das N
    Lupus; 2012 May; 21(6):596-603. PubMed ID: 22300832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression of cytokines (TNF-α, IFN-γ), serum profiles of IL-17 and IL-23 in paediatric systemic lupus erythematosus.
    Rana A; Minz RW; Aggarwal R; Anand S; Pasricha N; Singh S
    Lupus; 2012 Sep; 21(10):1105-12. PubMed ID: 22759859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proinflammatory cytokines (IL-6, TNF-α, and IL-1β) on clinical manifestations in Indian SLE patients.
    Umare V; Pradhan V; Nadkar M; Rajadhyaksha A; Patwardhan M; Ghosh KK; Nadkarni AH
    Mediators Inflamm; 2014; 2014():385297. PubMed ID: 25548434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1/Th2 cytokine profile in childhood-onset systemic lupus erythematosus.
    Postal M; Peliçari KO; Sinicato NA; Marini R; Costallat LT; Appenzeller S
    Cytokine; 2013 Mar; 61(3):785-91. PubMed ID: 23332615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.
    Miret C; Font J; Molina R; Garcia-Carrasco M; Filella X; Ramos M; Cervera R; Ballesta A; Ingelmo M
    Anticancer Res; 2001; 21(4B):3053-9. PubMed ID: 11712810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective?
    Gómez D; Correa PA; Gómez LM; Cadena J; Molina JF; Anaya JM
    Semin Arthritis Rheum; 2004 Jun; 33(6):404-13. PubMed ID: 15190525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue in patients with systemic lupus erythematosus: lack of associations to serum cytokines, antiphospholipid antibodies, or other disease characteristics.
    Omdal R; Mellgren SI; Koldingsnes W; Jacobsen EA; Husby G
    J Rheumatol; 2002 Mar; 29(3):482-6. PubMed ID: 11908560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated B lymphocyte stimulator levels are associated with increased damage in an Irish systemic lupus erythematosus cohort.
    McCarthy EM; Lee RZ; Ní Gabhann J; Smith S; Cunnane G; Doran MF; Howard D; O'Connell P; Kearns G; Jefferies CA
    Rheumatology (Oxford); 2013 Jul; 52(7):1279-84. PubMed ID: 23479724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
    Mahmoud RA; El-Gendi HI; Ahmed HH
    Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Proinflammatory cytokines in inactive lupus erythematosus patients].
    Lesiak A; Sysa-Jedrzejowska A; Narbutt J; Lukamowicz J; Robak E; Wozniacka A
    Przegl Lek; 2005; 62(9):838-42. PubMed ID: 16541713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of interferon gamma, tumor necrosis factor alpha and interleukin 6 serum levels with systemic lupus erythematosus activity.
    Robak E; Sysa-Jedrzejewska A; Dziankowska B; Torzecka D; Chojnowski K; Robak T
    Arch Immunol Ther Exp (Warsz); 1998; 46(6):375-80. PubMed ID: 9883317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of acute physical exercise on cytokine levels in patients with systemic lupus erythematosus.
    da Silva AE; dos Reis-Neto ET; da Silva NP; Sato EI
    Lupus; 2013 Dec; 22(14):1479-83. PubMed ID: 24135080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased serum β2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients.
    Hermansen ML; Hummelshøj L; Lundsgaard D; Hornum L; Keller P; Fleckner J; Fox B; Poulsen LK; Jacobsen S
    Lupus; 2012 Sep; 21(10):1098-104. PubMed ID: 22577117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.
    Mende R; Vincent FB; Kandane-Rathnayake R; Koelmeyer R; Lin E; Chang J; Hoi AY; Morand EF; Harris J; Lang T
    Front Immunol; 2018; 9():1250. PubMed ID: 29930551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine panel and histopathological aspects in the systemic lupus erythematosus.
    Avrămescu C; Biciuşcă V; Dăianu T; Turculeanu A; Bălăşoiu M; Popescu SN; Ionete O; Simionescu C
    Rom J Morphol Embryol; 2010; 51(4):633-40. PubMed ID: 21103619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus.
    Lit LC; Wong CK; Li EK; Tam LS; Lam CW; Lo YM
    J Rheumatol; 2007 Jan; 34(1):89-96. PubMed ID: 17117487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of functional interleukin 10/tumor necrosis factor-alpha polymorphisms on interferon-alpha, IL-10, and regulatory T cell population in patients with systemic lupus erythematosus receiving antimalarial treatment.
    López P; Gómez J; Prado C; Gutiérrez C; Suárez A
    J Rheumatol; 2008 Aug; 35(8):1559-66. PubMed ID: 18597405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.